Status:
COMPLETED
It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is Limited
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Feedback: during the COVID-19 epidemic, access to operating theaters was restricted so that anesthetists and nurse anesthetists could reinforce the resuscitation workforce. The MEOPA was used as an a...
Detailed Description
Colonoscopy is a major procedure for screening for cancers and diagnosing colorectal lesions. In France, general anesthesia remains the most widely used sedation method for colonoscopy. Faced with sev...
Eligibility Criteria
Inclusion
- Adult patients who had a colonoscopy under MEOPA between January 2019 and May 2021 at the CHSF.
Exclusion
- Colonoscopy under general anesthesia
- Refusal of data collection.
Key Trial Info
Start Date :
May 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2022
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT05336617
Start Date
May 13 2022
End Date
June 13 2022
Last Update
September 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106